Trevi Therapeutics Inc. (TRVI)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
16. 57
-0.03
-0.1807%
After Hours
$
+0.85 +5.1298% 17. 42
2.36B Market Cap
- P/E Ratio
- Div Yield
945,049 Volume
-0.39 Eps
$ 16.6
Previous Close 
Want to track TRVI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Trevi Therapeutics Inc. (TRVI) Statistics
Valuation metrics
Market Cap 2.36B
Enterprise value 2.33B
Trailing P/E (ttm) -49.7
Forward P/E -
PEG ratio -2.6
Price/Sales (ttm) -
Price/Book (mrq) 8.18
Enterprise Value/Revenue -
Enterprise Value/EBITDA -45.62
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.97M
Average volume (90 days) 2.91M
Price summary
52-Week low 6.93
52-Week high 20.22
Beta -
50-Day moving average 18.14
200-Day moving average 13.48
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.15%
Return on equity -0.24%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.04
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 37.28%
Book value per share (mrq) 2.05
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
